The Natural History of Nonalcoholic Fatty Liver Disease: Insights From Children and Mice

Gastroenterology

Volumn 135, Issue 6, 2008, Pages 1860-1862

  Ahima, Rexford S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1;

ADIPOSE TISSUE; CARDIOVASCULAR RISK; DYSLIPIDEMIA; EDITORIAL; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LIPID DIET; LIPID STORAGE; LIPOLYSIS; LIVER; LIVER BIOPSY; LIVER FUNCTION TEST; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PRIORITY JOURNAL;

EID: 57249094011     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.11.004     Document Type: Editorial

References (19)

1. Preiss D., and Sattar N. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci (Lond) 115 (2008) 141-150
2. Fracanzani A.L., Valenti L., Bugianesi E., et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology 48 (2008) 792-798
3. Roberts E.A. Pediatric nonalcoholic fatty liver disease (NAFLD): a "growing" problem?. J Hepatol 46 (2007) 1133-1142
4. Fraser A., Longnecker M.P., and Lawlor D.A. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology 133 (2007) 1814-1820
5. Chan D.F., Li A.M., Chu W.C., et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord 28 (2004) 1257-1263
6. Yoo J., Lee S., Kim K., et al. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children. Diabetes Res Clin Pract 81 (2008) 321-326
7. Schwimmer J.B., Behling C., Newbury R., et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 42 (2005) 641-649
8. Kleiner D.E., Brunt E.M., Van Natta M., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005) 1313-1321
9. Patton H.M., Lavine J.E., Van Natta M.L., et al. Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis (NASH). Gastroenterology 135 (2008) 1961-1971
10. Utzschneider K.M., and Kahn S.E. Review: The role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 91 (2006) 4753-4761
11. Postic C., and Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 118 (2008) 829-838
12. Day C.P. Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol 16 (2002) 663-678
13. Yamaguchi K., Yang L., McCall S., et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 45 (2007) 1366-1374
14. Rinella M.E., and Green R.M. The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. J Hepatol 40 (2004) 47-51
15. Rinella M.E., Elias M.S., Smolak R.R., et al. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. J Lipid Res 49 (2008) 1068-1076
16. Ota T., Takamura T., Kurita S., et al. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis. Gastroenterology 132 (2007) 282-293
17. Shimomura I., Hammer R.E., Richardson J.A., et al. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev 12 (1998) 3182-3194
18. Lee S.J., Heinrich G., Fedorova L., et al. Development of non-alcoholic steatohepatitis in insulin resistant L-SACC1 mice. Gastroenterology 135 (2008) 2084-2095
19. DeAngelis A.M., et al. Carcinoembryonic antigen-related cell adhesion molecule 1: a link between insulin and lipid metabolism. Diabetes 57 (2008) 2296-2303